Sat.May 08, 2021 - Fri.May 14, 2021

article thumbnail

EMA panel probes heart inflammation with Pfizer/BioNTech COVID vaccine

pharmaphorum

A review of side effects reported with coronavirus vaccines by the EMA’s safety committee has uncovered cases of inflammation of the heart in people receiving the Pfizer/BioNTech Comirnaty shot. . The Pharmacovigilance Risk Assessment Committee (PRAC) says it is aware of cases of myocarditis and pericarditis – inflammation of the heart muscle and membrane around the heart – with the vaccine.

Vaccines 122
article thumbnail

Researchers find CD38-targeting drugs may show promise against prostate cancer

Pharma Times

Researchers are initiating clinical trials to evaluate whether targeting the CD38 pathway can provide benefit for people with prostate cancer

115
115
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New patent expiration for Osi Pharms drug TARCEVA

Drug Patent Watch

Annual Drug Patent Expirations for TARCEVA Tarceva is a drug marketed by Osi Pharms and is included in one NDA. It is available from one supplier. There are two patents…. The post New patent expiration for Osi Pharms drug TARCEVA appeared first on DrugPatentWatch - Make Better Decisions.

98
article thumbnail

DarshanTalks: How To Build a Trusted Workforce – May 14, 2021

Pharma Marketing Network

[link]. The post DarshanTalks: How To Build a Trusted Workforce</br> – May 14, 2021 appeared first on Pharma Marketing Network.

96
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Coronavirus won’t be circulating in UK by August, says outgoing vaccine chief Clive Dix

pharmaphorum

Coronavirus won’t be circulating in the UK by August, according to the outgoing chief of the country’s vaccine rollout scheme, Dr Clive Dix. Dix led the programme from December until he stepped down last week and told the Daily Telegraph that the UK’s vaccination campaign should be enough to protect from the virus and its known variants by the summer.

Vaccines 124
article thumbnail

AZ/Daiichi Sankyo’s datopotamab deruxtecan demonstrates ‘promising’ early results in TNBC

Pharma Times

New data presented at the 2021 European Society of Medical Oncology (ESMO) Breast Cancer virtual congress

130
130

More Trending

article thumbnail

Maximize HCP Reach Through Purposeful Omnichannel or Multi-channel Digital Marketing

Pharma Marketing Network

Reaching healthcare professionals can certainly be challenging…especially with the disruption in the pharma marketing ecosystem caused by COVID-19. This disruption has accelerated the digital transformation in pharma. Pharma-marketers are embracing this digital transformation and are trying to understand the different dynamics of single, omni, and multi-channel approaches.

82
article thumbnail

BioNTech to set up mRNA manufacturing site in Singapore

pharmaphorum

BioNTech has said it plans to set up a regional base and new manufacturing site in Singapore so that the biotech can keep pace with demand for its mRNA-based coronavirus vaccine and pipeline products in other disease areas. The German firm said the production facility will be able to produce several hundred million doses of mRNA-based vaccine, depending on the requirements of the specific vaccine.

Vaccines 127
article thumbnail

Positive CHMP opinion for self-administered Crysvita

Pharma Times

Crysvita is used for the treatment of the rare metabolic bone disease X-linked hypophosphataemia (XLH)

121
121
article thumbnail

Could synthetic biology solutions fix supply chain challenges?

Outsourcing Pharma

An expert from synthetic biology tech firm Antheia offers ways to rethink current sourcing and manufacturing strategies to tackle current and future woes.

75
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

FDA Authorizes Pfizer-BioNTech Vaccine for Children 12 to 15

NY Times

The shots may allow millions of youngsters to get back to school, camps, sleepovers and hangouts with friends.

article thumbnail

AI in action: Report highlights the real-world benefits of AI in healthcare

pharmaphorum

Joined up thinking is the key to converting AI-driven advances into real benefits for healthcare systems, say NHSX. Healthcare systems the world over have been facing the same challenges for some time – and the pandemic has only served to compound them. Aging populations, a growing number of people living with long-term conditions, and dwindling resources meant the NHS was already being asked to do more with less before COVID-19 hit.

article thumbnail

US approves Pfizer COVID-19 vaccine for children aged 12 to 15

Pharma Times

First COVID-19 jab to be approved for emergency use in the US for this younger age group

Vaccines 108
article thumbnail

A Look Into Telehealth in 2021 and Beyond

Pharma Marketing Network

According to a stat by Medgadget, “Global Telemedicine Market is valued at USD 27.04 Billion in 2019 and Expected to Reach USD 171.81 Billion by 2026 with a CAGR of 37.2% over the Forecast Period.”. The COVID-19 pandemic seriously accelerated the adoption and implementation of telehealth services, like remote patient monitoring and out-of-office “visits” – a trend that was already on the incline.

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Cancer drug developer aims to transform treatment

Outsourcing Pharma

A leader from clinical-stage pharma firm NuCana shares promising results for its ProTides therapies and hopes the drugs can elevate outcomes for patients.

article thumbnail

Moderna’s founder launches Laronde, promising new ‘Endless RNA’ drug class

pharmaphorum

Flagship Pioneering, the VC fund run by Moderna’s co-founder Noubar Afeyan has launched a new biotech Laronde , with an ambitious plan to create a new class of drugs based on Endless RNA. Called eRNA for short, this class of medicines is programmable and can continuously express therapeutic proteins inside the body. This makes the body into a “drug factory”, allowing for long-lasting medicines that allow for repeat redosing and can be administered easily by several routes.

article thumbnail

WHO grants Sinopharm’s COVID-19 vaccine emergency approval

Pharma Times

First COVID-19 jab developed by a non-Western company to gain this recommendation

Vaccines 112
article thumbnail

Which pharmaceutical companies have the most SPCs in Lithuania?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Lithuania. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…. The post Which pharmaceutical companies have the most SPCs in Lithuania? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Industry veteran suggests solutions to strengthen clinical care

Outsourcing Pharma

In this second part of a series on the state of clinical research, a leader from Javara lays out ideas to bring clinical research and care closer together.

59
article thumbnail

Birdie raises $11.5m to develop care at home app

pharmaphorum

The care technology firm Birdie has raised $11.5 million to develop its app to help providers deliver elderly care at home. In a statement the UK firm said the fundraiser led by international VC Index Ventures and with participation from Kamet Ventures will be used to grow its business and develop its product. Birdie said its app can help care providers to efficiently deliver more coordinated, personalised and preventative care.

article thumbnail

MHRA approves label extension for Vertex’s Kaftrio combo

Pharma Times

Extension of indication expands access to drug for additional cystic fibrosis patients in Great Britain

article thumbnail

Which pharmaceutical drugs have the most drug patents in Iceland?

Drug Patent Watch

This chart shows the drugs with the most patents in Iceland. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Iceland? appeared first on DrugPatentWatch - Make Better Decisions.

52
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Novasep expands in France, sees increasing customer demand for ADC manufacturing services

Outsourcing Pharma

Novasep has announced a further expansion of its Highly Potent Active Pharmaceutical Ingredients (HPAPIs) manufacturing capabilities at its Le Mans, France site, saying the move strengthens its position as a leading CDMO for the production of innovative and targeted molecules to treat cancer.

52
article thumbnail

Alvotech files lawsuit challenging AbbVie’s Humira patent thicket

pharmaphorum

Biosimilars firm Alvotech has filed a lawsuit that challenges AbbVie’s legal defences surrounding the inflammatory disease drug Humira in the US. Alvotech is challenging the patent thicket surrounding Humira, a common ploy in pharma that seems to be particularly effective in the US. Several biological drugs have remained unchallenged on the US market thanks to a legal force-field from supplementary patents, after the main patent has expired and after protection has lapsed in Europe and other cou

article thumbnail

Abbott’s AI-powered coronary imaging platform deployed in the UK

Pharma Times

Heart attack patients offered treatment with new technology at the Royal Free Hospital in London

article thumbnail

New patent for Astrazeneca Ab drug BYDUREON

Drug Patent Watch

Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are thirty-six patents…. The post New patent for Astrazeneca Ab drug BYDUREON appeared first on DrugPatentWatch - Make Better Decisions.

52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Prescribing and Policy Trends Affecting Medication Access in 2021

Drug Channels

Today’s guest post comes from Kyle Grimslid, Clinical Solutions Director at CoverMyMeds. Kyle discusses the prescribing trends and policies that emerged in 2020. He highlights the growing importance of pharmacists and the role of technology in improving patient access, affordability, and adherence. Read more in CoveryMyMeds’ 2021 Medication Access Report: Legislative and Regulatory Edition.

52
article thumbnail

How a lack of mental health diagnosis is affecting young men

pharmaphorum

As lockdown gradually eases, things are starting to look up but the lasting impact COVID-19 has had on our wellbeing remains. During Mental Health Awareness Month we look at the mental health stigma amongst men. To say we’re in the midst of a mental health crisis is not an exaggeration. Mental health concerns have been increasing for years and have only been amplified by the COVID-19 crisis and national lockdowns.

100
100
article thumbnail

NICE rejects Pfizer’s rare heart disease treatment Vyndaqel

Pharma Times

The final guidance publication comes following an appeal against earlier draft recommendations

94
article thumbnail

New patent for Astrazeneca Ab drug BYDUREON PEN

Drug Patent Watch

Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-two…. The post New patent for Astrazeneca Ab drug BYDUREON PEN appeared first on DrugPatentWatch - Make Better Decisions.

52
article thumbnail

QED Advocates New British Standard for Soil Sampling

Pharma Mirror

Industry specialists working on contaminated land are being urged to use the new British Standard BS 10176 for soil sampling. BS 10176 was introduced in August 2020 but tests using old methods, which do not conform to the new standard, are still being accepted by regulators and assessors, which has led to concerns that its use is still only sporadic.

52